Cell Cycle in Development pp 565-576

Part of the Results and Problems in Cell Differentiation book series (RESULTS)

Cell Cycle Deregulation in the Neurons of Alzheimer’s Disease

  • Calvin Moh
  • Jacek Z. Kubiak
  • Vladan P. Bajic
  • Xiongwei Zhu
  • Mark A. Smith
  • Hyoung-gon Lee


The cell cycle consists of four main phases: G1, S, G2, and M. Most cells undergo these cycles up to 40–60 times in their life. However, neurons remain in a nondividing, nonreplicating phase, G0. Neurons initiate but do not complete cell division, eventually entering apoptosis. Research has suggested that like cancer, Alzheimer’s disease (AD) involves dysfunction in neuronal cell cycle reentry, leading to the development of the two-hit hypothesis of AD. The first hit is abnormal cell cycle reentry, which typically results in neuronal apoptosis and prevention of AD. However, with the second hit of chronic oxidative damage preventing apoptosis, neurons gain “immortality” analogous to tumor cells. Once both of these hits are activated, AD can develop and produce senile plaques and neurofibrillary tangles throughout brain tissue. In this review, we propose a mechanism for neuronal cell cycle reentry and the development of AD.


  1. Bajic VP, Spremo-Potparevic B, Zivkovic L, Bonda DJ, Siedlak SL, Casadesus G, Lee HG, Smith MA (2009) The X-chromosome instability phenotype in Alzheimer’s disease: a clinical sign of accelerating aging? Med Hypotheses 73:917–920PubMedCentralPubMedCrossRefGoogle Scholar
  2. Bonda DJ, Bajic VP, Spremo-Potparevic B, Casadesus G, Zhu X, Smith MA, Lee HG (2010) Cell cycle aberrations and neurodegeneration: a review. Neuropathol Appl Neurobiol 36:157–163PubMedCrossRefGoogle Scholar
  3. Castellani RJ, Lee HG, Siedlak SL, Nunomura A, Hayashi T, Nakamura M, Zhu X, Perry G, Smith MA (2009) Reexamining Alzheimer’s disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. J Alzheimers Dis 18:447–452PubMedCentralPubMedGoogle Scholar
  4. Castellani RJ, Rolston RK, Smith MA (2010) Alzheimer disease. Dis Mon 56:484–546PubMedCentralPubMedCrossRefGoogle Scholar
  5. Conde C, Caceres A (2009) Microtubule assembly, organization and dynamics in axons and dendrites. Nat Rev Neurosci 10:319–332PubMedCrossRefGoogle Scholar
  6. Ding XL, Husseman J, Tomashevski A, Nochlin D, Jin LW, Vincent I (2000) The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer’s disease. Am J Pathol 157:1983–1990PubMedCrossRefGoogle Scholar
  7. Evans TA, Raina AK, Delacourte A, Aprelikova O, Lee HG, Zhu X, Perry G, Smith MA (2007) BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. Int J Med Sci 4:140–145PubMedCentralPubMedCrossRefGoogle Scholar
  8. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913–4917PubMedCrossRefGoogle Scholar
  9. Haapasalo A, Viswanathan J, Bertram L, Soininen H, Tanzi RE, Hiltunen M (2010) Emerging role of Alzheimer’s disease-associated ubiquilin-1 in protein aggregation. Biochem Soc Trans 38:150–155PubMedCrossRefGoogle Scholar
  10. Hampton MB, Fadeel B, Orrenius S (1998) Redox regulation of the caspases during apoptosis. Ann N Y Acad Sci 854:328–335PubMedCrossRefGoogle Scholar
  11. Hayashi T, Shishido N, Nakayama K, Nunomura A, Smith MA, Perry G, Nakamura M (2007) Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Free Radic Biol Med 43:1552–1559PubMedCrossRefGoogle Scholar
  12. Hernandez-Ortega K, Ferrera P, Arias C (2007) Sequential expression of cell-cycle regulators and Alzheimer’s disease-related proteins in entorhinal cortex after hippocampal excitotoxic damage. J Neurosci Res 85:1744–1751PubMedCrossRefGoogle Scholar
  13. Iqbal K, Zaidi T, Thompson CH, Merz PA, Wisniewski HM (1984) Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol 62:167–177PubMedCrossRefGoogle Scholar
  14. Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802:396–405PubMedCrossRefGoogle Scholar
  15. Kim WY, Shen J (2008) Presenilins are required for maintenance of neural stem cells in the developing brain. Mol Neurodegener 3:2PubMedCentralPubMedCrossRefGoogle Scholar
  16. Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823PubMedCrossRefGoogle Scholar
  17. Korenberg JR, Pulst SM, Neve RL, West R (1989) The Alzheimer amyloid precursor protein maps to human chromosome 21 bands q21.105-q21.05. Genomics 5:124–127PubMedCrossRefGoogle Scholar
  18. Kubiak J, Smith MA (2010) Ubiquitin/proteasome system in mitotic and mitotic-like regulation during brain development and pathology. In: Di Napoli M, Wojcik C (eds) The ubiquitin proteasome system in the central nervous system: from physiology to pathology – 2008 update. Nova Science, Hauppauge, NY, pp 113–130Google Scholar
  19. Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, Takeda A, Nunomura A, Smith MA (2005) Tau phosphorylation in Alzheimer’s disease: pathogen or protector? Trends Mol Med 11:164–169PubMedCrossRefGoogle Scholar
  20. Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, Smith MA (2009) The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 174:891–897PubMedCrossRefGoogle Scholar
  21. Lopes JP, Oliveira CR, Agostinho P (2009) Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides. Cell Cycle 8:97–104PubMedCrossRefGoogle Scholar
  22. McShea A, Harris PL, Webster KR, Wahl AF, Smith MA (1997) Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer’s disease. Am J Pathol 150:1933–1939PubMedGoogle Scholar
  23. Moreira PI, Santos MS, Oliveira CR, Shenk JC, Nunomura A, Smith MA, Zhu X, Perry G (2008) Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 7:3–10PubMedCrossRefGoogle Scholar
  24. Nakamura M, Shishido N, Nunomura A, Smith MA, Perry G, Hayashi Y, Nakayama K, Hayashi T (2007) Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Biochemistry 46:12737–12743PubMedCrossRefGoogle Scholar
  25. Nguyen MD, Mushynski WE, Julien JP (2002) Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ 9:1294–1306PubMedCrossRefGoogle Scholar
  26. Ogawa O, Zhu X, Lee HG, Raina A, Obrenovich ME, Bowser R, Ghanbari HA, Castellani RJ, Perry G, Smith MA (2003) Ectopic localization of phosphorylated histone H3 in Alzheimer’s disease: a mitotic catastrophe? Acta Neuropathol 105:524–528PubMedGoogle Scholar
  27. Raina AK, Zhu X, Rottkamp CA, Monteiro M, Takeda A, Smith MA (2000) Cyclin’ toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res 61:128–133PubMedCrossRefGoogle Scholar
  28. Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomura A, Siedlak SL, Boux H, Castellani RJ, Perry G, Smith MA (2001) Abortive apoptosis in Alzheimer’s disease. Acta Neuropathol 101:305–310PubMedGoogle Scholar
  29. Robakis NK (2010) Are Abeta and its derivatives causative agents or innocent bystanders in AD? Neurodegener Dis 7:32–37PubMedCrossRefGoogle Scholar
  30. Sakono M, Zako T (2010) Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J 277:1348–1358PubMedCrossRefGoogle Scholar
  31. Smith MA, Casadesus G, Joseph JA, Perry G (2002) Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 33:1194–1199PubMedCrossRefGoogle Scholar
  32. Smith MA (2006) Oxidative stress and iron imbalance in Alzheimer disease: how rust became the fuss! J Alzheimers Dis 9:305–308PubMedGoogle Scholar
  33. Sousa M, Barros A, Silva J, Tesarik J (1997) Developmental changes in calcium content of ultrastructurally distinct subcellular compartments of preimplantation human embryos. Mol Hum Reprod 3:83–90PubMedCrossRefGoogle Scholar
  34. Spremo-Potparevic B, Zivkovic L, Djelic N, Plecas-Solarovic B, Smith MA, Bajic V (2008) Premature centromere division of the X chromosome in neurons in Alzheimer’s disease. J Neurochem 106:2218–2223PubMedCentralPubMedCrossRefGoogle Scholar
  35. Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, Pronzato MA, Danni O, Smith MA, Perry G, Tabaton M (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10:279–288PubMedCrossRefGoogle Scholar
  36. Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Guglielmotto M, Santoro G, Davit A, Danni O, Smith MA, Perry G, Tabaton M (2005) Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem 92:628–636PubMedCrossRefGoogle Scholar
  37. Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca G, Danni O, Zhu X, Smith MA, Perry G, Jo DG, Mattson MP, Tabaton M (2008) Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J Neurochem 104:683–695PubMedCentralPubMedGoogle Scholar
  38. Tan Z, Sun X, Hou FS, Oh HW, Hilgenberg LG, Hol EM, van Leeuwen FW, Smith MA, O’Dowd DK, Schreiber SS (2007) Mutant ubiquitin found in Alzheimer’s disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death Differ 14:1721–1732PubMedCentralPubMedCrossRefGoogle Scholar
  39. Tank EM, True HL (2009) Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates. PLoS Genet 5:e1000382PubMedCentralPubMedCrossRefGoogle Scholar
  40. Thakur A, Wang X, Siedlak SL, Perry G, Smith MA, Zhu X (2007) c-Jun phosphorylation in Alzheimer disease. J Neurosci Res 85:1668–1673PubMedCrossRefGoogle Scholar
  41. Udvardy A (1996) The role of controlled proteolysis in cell-cycle regulation. Eur J Biochem 240:307–313PubMedCrossRefGoogle Scholar
  42. Vincent I, Jicha G, Rosado M, Dickson DW (1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer’s disease brain. J Neurosci 17:3588–3598PubMedGoogle Scholar
  43. Vincent I, Zheng JH, Dickson DW, Kress Y, Davies P (1998) Mitotic phosphoepitopes precede paired helical filaments in Alzheimer’s disease. Neurobiol Aging 19:287–296PubMedCrossRefGoogle Scholar
  44. Vincent I, Bu B, Hudson K, Husseman J, Nochlin D, Jin L (2001) Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer’s disease. Neuroscience 105:639–650PubMedCrossRefGoogle Scholar
  45. Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer’s disease. J Neurochem 76:435–441PubMedCrossRefGoogle Scholar
  46. Zhu X, Ogawa O, Wang Y, Perry G, Smith MA (2003) JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer’s disease. J Neurochem 85:87–93PubMedCrossRefGoogle Scholar
  47. Zhu X, Raina AK, Perry G, Smith MA (2004a) Alzheimer’s disease: the two-hit hypothesis. Lancet Neurol 3:219–226PubMedCrossRefGoogle Scholar
  48. Zhu X, Wang Y, Ogawa O, Lee HG, Raina AK, Siedlak SL, Harris PL, Fujioka H, Shimohama S, Tabaton M, Atwood CS, Petersen RB, Perry G, Smith MA (2004b) Neuroprotective properties of Bcl-w in Alzheimer disease. J Neurochem 89:1233–1240PubMedCrossRefGoogle Scholar
  49. Zhu X, Lee HG, Perry G, Smith MA (2007) Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta 1772:494–502PubMedCrossRefGoogle Scholar
  50. Zhu X, Siedlak SL, Wang Y, Perry G, Castellani RJ, Cohen ML, Smith MA (2008) Neuronal binucleation in Alzheimer disease hippocampus. Neuropathol Appl Neurobiol 34:457–465PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Calvin Moh
    • 1
  • Jacek Z. Kubiak
    • 2
  • Vladan P. Bajic
    • 3
  • Xiongwei Zhu
    • 1
  • Mark A. Smith
    • 1
  • Hyoung-gon Lee
    • 1
  1. 1.Department of PathologyCase Western Reserve UniversityClevelandUSA
  2. 2.CNRS UMR 6061, Institute of Genetics and Development, Cell Cycle GroupUniversity of Rennes 1, IFR 140 GFASRennesFrance
  3. 3.Institute of Biomedical Research, Galenika a.dBelgradeSerbia

Personalised recommendations